Avanafil CAS#330784-47-9; Vildagliptin CAS#274901-16-5

For the treatment of prematureejaculation(PE) in men aged 18 to 64 years old. Enterprise standard with a content of 99%. Specification: USP, EP, BP, CHP. Documentation: DMF, WC, COA, GMP.

For the treatment and prevention of influenza A and B in adults and children one year and older. Specification: USP, EP, BP, CHP Documentation: DMF, WC, COA, GMP

For the treatment of erectile dysfunction. Specification: USP, EP, BP Documentation: DMF, WC, GMP, COA

For the treatment of penile erectiledys function in men. Specification: USP, EP, BP Documentation: DMF, WC, COA, GMP

This product is indicated for premature ejaculation(PE) in men aged 18 to 64 years. 

For the treatment and prevention of influenza A and B in adults and children one year and older. 

For the treatment of penile erectile dysfunction in men.

For the treatment of erectile dysfunction for men.

For the treatment of penile erectile dysfunction in men.

The APIs and intermediates which producing by ourself included in this this product list.